BioReliance Corp. has launched iNet, an IT system that enables customers to submit test article details via controlled and secure Internet access from any location worldwide. Clients can view the status of current and past studies, view expected completion dates, download reports, and allow colleagues to view testing status—all in one online environment and in real-time, according to the company.

Tim Derrington, president and chief executive officer of BioReliance, stated, “Our customers are now armed with a web-enabled application that offers a precise picture of their project’s current and future status. We look forward to greatly expanding our iNet user base in the upcoming months and continuing to develop and integrate new technologies that will enhance our customers’ service experiences with BioReliance.”

Judith Apshago, senior director of global IT, added, “A lot of effort was placed into making iNet user-friendly, secure and compliant. As a result, preliminary users have navigated through the submission process with little difficulty. In addition, we have implemented multiple layers of security both on the front end and the back end to create an extremely secure online environment that validates users and ensures data integrity.”

iNet is compliant with 21 CFR Part 11 for user authentication, and data exchange over the web is protected by VeriSign. It’s compatible with both Windows and Mac operating systems.